Clinical Trials Browser

Phase 2 × Axitinib × Other hematologic neoplasm × Clear all

NCT00071006 2012-06-08

AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)

Phase 2 Completed

12 enrolled 5 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute